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Abstract 
Background: Premature menopause is characterized by amenorrhea before age of 40 years, markedly raised se-
rum luteinizing hormone (LH) level, follicle-stimulating hormone (FSH) level and reduced serum level of estradiol. 
Genome-wide analysis suggested several loci associated with premature menopause. Here, we aimed to analyze as-
sociation of variants at the MCM8, FNDC4, PRRC2A, TLK1, ZNF346 and TMEM150B gene loci with premature 
menopause.
Materials and Methods: In this cross-sectional study, a total of 117 women with premature menopause were com-
pared to 183 healthy women. Anthropometric indices were measured in all participants: height, weight, body mass in-
dex (BMI), waist circumference (WC) and wrist circumference. Eight single-nucleotide polymorphisms (SNPs) of the 
indicated genes (rs16991615, rs244715, rs451417, rs1046089, rs7246479, rs4806660, rs10183486 and rs2303369) 
were identified from the literature. Genotyping was performed using tetra-ARMS polymerase chain reaction (PCR) 
and ASO-PCR methods.
Results: T allele of the rs16991615, rs1046089, rs7246479 and rs10183486, C allele of rs244715, rs451417 and 
rs4806660 as well as TT genotype of rs2303369 were associated with an increased risk of premature menopause, 
likely causing susceptibility to primary ovarian insufficiency (POI) in comparison with C allele. We also found an 
association between the rs16991615 SNP with premature menopause. Frequency of the minor allele in cases was 
increased for all SNPs in comparison with controls. All minor alleles, except for rs2303369, showed a statistically 
significant increased odds ratio (OR). However, after Bonferroni correction for multiple testing, none of the P values 
were remained significant.
Conclusion: The selected polymorphisms in MCM8, FNDC4, PRRC2A, TLK1, ZNF346 and TMEM150B genes 
may potentially affect susceptibility to premature menopause, although replication of the results in larger cohort could 
clarify this. 
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Introduction
Premature menopause or primary ovarian insufficiency 
(POI) is the occurrence of menopause before age of 40 
years (1). This condition is characterized by amenorrhea, 
increased luteinizing hormone (LH) level, follicle-stim-
ulating hormone (FSH) level and reduced level of estra-
diol. POI may be idiopathic or associated with autoim-
mune and genetic abnormalities (2). Other than that, fac-
tors such as infections, chemo and radiotherapy, surgery 
and adverse effects of drugs could also be contributory 
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(3, 4). POI may lead to increase of all-cause mortality, 
cardiovascular diseases, depression, type 2 diabetes and 
increased risk of bone fracture (5-8). 
Genetic factors appear to be responsible for approxi-
mately 50% of the variations in the onset of menarche and 
menopause (9). Several studies have found different ge-
netic loci associated with age at natural menopause (ANM) 
(10-14). DNA repair genes such as EXO1, HELQ, UIMC1, 
FAM175A, FANCI, TLK1, POLG and PRIM1 along with 
genes like IL11, NLRP11 and PRRC2A which are involved 
in immune function, are located at these loci (14). 
Mutations in some of these genes have been indicated 
to be involved in POI. For example, Tenenbaum-Rako-
ver et al. (15) found two new homozygous mutations in 
the MCM8 gene, a frameshift (c.1469-1470insTA) and 
a splice site mutation (c.1954-1G>A). These mutations 
were shown to increase the risk of chromosomal break-
age after mitomycin C exposure. The authors also found 
that MCM8 plays a pivotal role in gonadal development. 
Desai et al. (16) also found that mutations in MCM8 and 
MCM9 could be a significant risk factor for POI. Besides, 
several other studies have replicated findings obtained 
from rs16991615 polymorphism, located in MCM8, as a 
significant single-nucleotide polymorphism (SNP) asso-
ciated with ANM in different populations (17, 18). Llácer 
et al. (19) showed that IL11- rs11668344 and PRRC2A- 
rs1046089 are associated with poor ovarian response in-
dicating that women carrying these polymorphisms have 
decreased oocyte production in response to controlled 
ovarian hyper stimulation. On this basis, we selected eight 
different SNPs in the genes more commonly associated 
with POI. They have not previously been studied in the 
Iranian population. We aimed to determine whether these 
SNPs are involved in the development of premature men-
opause and to find their association with anthropometric 
characteristics in a population sample from Mashhad city 
in Iran.
Materials and Methods
Studying participants and anthropometric indices
In this cross-sectional study, a total of 117 women 
who were originally enrolled in the Mashhad stroke 
and heart atherosclerotic disorder (MASHAD) study 
were recruited and compared to 183 healthy women. 
"MASHAD study" is a 10-years cohort study of a total 
of 9704 individuals aged 35-65 years, from an urban 
population in eastern part of Iran. They were selected 
using a stratified cluster random sampling design. The 
healthy group was chosen from women without history 
of menopause before the age of 40 years to match with 
the cases group in terms of age. The cases were also 
selected from this study cohort based on their history 
of premature menopause. A complete history was tak-
en for all subjects, including any surgical procedures, 
acute or chronic diseases, chemotherapy or radiation 
therapy, smoking habit, medications as well as the re-
sults of periodic examinations. Women who were not 
willing to enroll in the present study, were excluded. 
We included all eligible and available volunteer women 
who met the study criteria. To clarify this, 9704 people 
participated in "MASHAD study" project. 5838 of the 
cases were women. 2747 women reached menopause 
by the time of starting study. Furthermore, 895 women 
were removed from the project (due to hysterectomy, 
oophorectomy and other secondary causes). Out of the 
1852 remaining women, 117 (all the cases existed in 
the population) cases were below the age of 40 years 
at their menopause. They were selected according to 
the POI definition, including: i. Women going through 
menopause before the age of 40 years, ii. 12 months of 
consecutive menstrual cessation or iii. Elevated serum 
FSH levels >40 IU/L (repeated at four-week intervals) 
(1). Other inclusion criteria were provided as follows: 
women with POI, women younger than 40 years old, 
women without history of diseases affecting menstrua-
tion, women without any genetically confirmed diseas-
es or syndromes that early menopause was part of their 
manifestations, women without any previous surgeries 
affecting menstruation (oophorectomy, hysterectomy) 
and women who were not using any drugs affecting 
menstruation. Hence, 117 women were considered 
eligible to be enrolled in the present study. Anthropo-
metric indices such as height, weight, body mass index 
(BMI), waist circumference (WC) and wrist circumfer-
ence were measured in all participants. Informed con-
sent was obtained from all participants. The approval 
number from the constituted review board, the Ethics 
Committee of Mashhad University of Medical Scienc-
es is IR.MUMS.MEDICAL.REC.1398.658.
Genotyping
DNA extraction and quality control
Total genomic DNA was extracted from 200 µl blood or 
buffy coat using a DNA extraction kit (Parstous, Iran). Af-
ter DNA extraction, the samples were loaded and run on 
agarose gel (Parstous, Iran). Quantification of the DNA 
samples was evaluated by Nanodrop 2000 (Thermo Fish-
er Scientific, USA) at wave length of 280 and 260 nm.
Tetra-ARMS polymerase chain reaction
Tetra-ARMS polymerase chain reaction (PCR) was 
carried out in 15 µl reaction volume containing 1 µl of 
each primer (0.6 pM of each primer), 7.5 µl master mix 
(Parstous, Iran), 2 µl genomic DNA and 1.5 µl water. 
Primers were designed using Primer 1 software. Tetra-
ARMS PCR was conducted with an initial denatura-
tion step at 95°C for 5 minutes, followed by 30 cycles 
of denaturation at 94°C for 30 seconds, annealing at 
58°C for 30 seconds and extension at 72°C for 40 sec-
onds. Final extension step was performed at 72°C for 5 
minutes. The sequences of all primers are summarized 
in Table S1 (See Supplementary Online Information at 
www.ijfs.ir). Sanger sequencing was performed to con-
firm the results.
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Allele-specific oligonucleotide polymerase chain reaction
Allele-specific oligonucleotide PCR (ASO-PCR) was 
performed in a 15 µl reaction volume containing 1 µl of 
each primer (4 µM), 7.5 µl master mix (Parstous, Iran), 
2 µl genomic DNA and 1.5 µl water. Primers were de-
signed using Primer 3 software. PCR was carried out 
with the following condition: one cycle of initial dena-
turation at 95°C for 7 minutes, followed by 35 cycles in-
cluding 95°C for 30 seconds, annealing for 30 seconds, 
72°C for 30 seconds, followed by one cycle of 7 minutes 
for the final extension. The sequences of all primers are 
summarized in Table S1 (See Supplementary Online In-
formation at www.ijfs.ir). The sample data are presented 
in Figure 1. 
Fig.1: The RS4806660 Gel electrophoresis. Tetra- ARMS polymerase chain 
reaction (PCR) products were loaded and run on 2% agarose gel. 
Statistical analysis
All experiments were performed in triplicate and re-
ported values were displayed as mean ± standard devia-
tion (SD). All data were analyzed using Microsoft Excel 
and SPSS version 24 (SPSS Inc., USA). t test statistical 
analysis was applied for comparing mean differences be-
tween two independent groups, and One-way ANOVA 
test was used to compare mean differences between more 
than two groups. Chi-square test was performed to ana-
lyze the Hardy-Weinberg equilibrium. Binary logistic re-
gression test was used to calculate the odds ratio (OR) and 
confidence interval (CI) based on genotype data. Univari-
ate and multivariate analysis were applied for the poly-
morphisms. Significance level is shown with *P<0.05, ** 
P<0.01 and ***P<0.001. Where applicable, Bonferroni 
correction was used to correct for multiple testing.
Results
Study of population characteristics
The mean age was 55.21 ± 5.56 years for the cases 
and 54.62 ± 2.89 years for the controls (P=0.411). A 
significant difference was observed between the average 
heights, waist circumference, weight, waist/height ratio 
and waist/hip ratio (WHR) of both groups. The controls 
were significantly heavier (70.96 ± 10.80 Kg) than the 
cases (67.11 ± 12.03 Kg, P<0.001). In contrast, the 
waist/height ratio was higher in the patients (63.55 ± 
8.41 ) compared to the healthy subjects (60.30 ± 6.84, 
P=0.001). WHR was also greater in patients (0.93 ± 
0.08 ) than controls (0.89 ± 0.07, P=0.001). The data are 
summarized in Table 1.
Table 1: Demographic features and characteristics of the study population
Indices Case Control P value
Age (Y) 55.21 ± 5.56 54.62 ± 2.89 0.411
Height (m) 1.53 ± 0.06 1.56 ± 0.06 0.001
Waist circumference (cm) 96.96 ± 12.19 93.70 ± 10.44 0.020
Weight (kg) 67.11 ± 12.03 70.96 ± 10.80 <0.001
Hip circumference (cm) 104.71 ± 9.85 105.57 ± 8.78 0.430
Waist/height ratio 63.55 ± 8.41 60.30 ± 6.84 0.001
Waist/hip ratio 0.93 ± 0.08 0.89 ± 0.07 0.001
Mid upper circumference (cm) 30.69 ± 4.47 31.02 ± 4.61 0.550
Body mass index (kg/m2) 28.78 ± 5.06 29.34 ± 4.22 0.300
Data are presented as mean ± SD.
Association of the single nucleotide polymorphisms 
and premature menopause
A total of eight SNPs were investigated in this study: 
rs16991615, rs244715, rs451417, rs1046089, rs7246479, 
rs4806660, rs10183486 and rs2303369. The genotype 
and allele frequencies of these SNPs are shown in Table 2. 
All SNPs conformed to the Hardy-Weinberg equilibrium. 
We found that the T allele of rs16991615, rs1046089, 
rs7246479 and rs10183486 as well as the C allele of 
rs244715, rs451417 and rs4806660 were associated with 
increased risk of premature menopause, in addition to 
the TT genotype of rs2303369 which may increase the 
susceptibility to POI in comparison with C allele careers. 
Besides, using a recessive model, genotypes of all SNPs 
were associated with an elevated risk of the disease 
(Table 3). Our results also suggested that CT genotype of 
rs7246479 was associated with increased susceptibility to 
premature menopause in comparison with CC genotype 
(OR=1.92, 95% CI=1.16-3.18, P=0.01). Furthermore, 
dominant model showed that genotype frequency of 
CC+TC was associated with increased risk of premature 
menopause for rs244715 (OR=1.70, 95% CI=1.06-2.72, 
P=0.027) in comparison with TT, while the T allele 
careers of rs1046089 (OR=1.71, 95% CI=1.05-2.79, 
P=0.03) and rs7246479 (OR=2.13, 95% CI=1.30-3.47, 
P=0.002) showed a greater association with risk for POI 
in comparison with CC. The additive model also indicated 
that TT genotype of rs16991615, rs1046089, rs10183486 
and rs2303369, as well as CC genotype of rs451417 
and rs4806660, were associated with increased risk of 
premature menopause, more than 100%. We acknowledge 
that although in the initial analysis some of these SNPs 
seemed to be associated with premature menopause, after 
correction for multiple testing none of them remained 
significant, as explained in Table 4.
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Table 2: Genotype distribution and allele frequencies of the single nucleotide polymorphism (SNPs)
SNP Genotype frequency HWE
Case (117) Alleles Control (183) Alleles P value
AA Aa aa A a AA Aa aa A a 
rs16991615 (G>A) 44 39 29 0.57 0.43 96 79 18 0.66 0.33 0.95
rs244715 (A>G) 59 46 12 0.70 0.3 116 61 6 0.80 0.20 0.83
rs451417 (A>C) 48 36 33 0.56 0.43 87 76 20 0.68 0.32 0.85
rs1046089 (G>A) 37 59 21 0.56 0.44 81 89 13 0.69 0.31 0.22
rs7246479 (G/T) 36 67 14 0.60 0.4 89 86 8 0.72 0.28 0.07
rs4806660 (T>C) 50 53 14 0.65 0.34 94 82 7 0.74 0.26 0.10
rs10183486 (C>T) 47 55 15 0.64 0.36 93 81 9 0.73 0.27 0.25
rs2303369 (C>T) 42 54 21 0.59 0.41 77 90 16 0.67 0.33 0.35
Table 3: OR based on different models
SNP Additive model (aa vs. Aa) P value Dominant model ( aa+Aa vs. AA) P value
 OR (95% CI)  OR (95% CI)  
rs16991615 (G>A) 3.26 (1.61-6.58) 0.001 1.52 (0.95- 2.45) 0.078
rs244715 (A>G) 2.65 (0.92-7.59) 0.069 1.70 (1.06-2.72) 0.027
rs451417 (A>C) 3.48 (1.76-6.89) <0.001 1.30 (0.81-2.08) 0.269
rs1046089 (G>A) 2.43 (1.13-5.24) 0.023 1.71 (1.05-2.79) 0.03
rs7246479 (G/T) 2.24 (0.89-5.66) 0.087 2.13 (1.30-3.47) 0.002
rs4806660 (T>C) 3.09 (1.17-8.16) 0.023 1.41 (0.88-2.25) 0.145
rs10183486 (C>T) 2.45 (1.00-6.00) 0.050 1.53 (0.96-2.46) 0.070
rs2303369 (C>T) 2.18 (1.05-4.55) 0.040 1.29 (0.80-2.09) 0.290
Allelic model (a vs. A)  Homozygote contrast (aa vs. AA)  
rs16991615 (G>A) 1.79 (1.27-2.53) 0.001 3.51 (1.76-6.99) 0.001
rs244715 (A>G) 1.71 (1.17- 2.50) 0.005 3.93 (1.40-11.00) 0.009
rs451417 (A>C) 1.66 (1.18-2.33) 0.003 2.99 (1.54-5.77) 0.001
rs1046089 (G>A) 1.65 (1.17-2.32) 0.004 3.53 (1.59-7.81) 0.002
rs7246479 (G/T) 1.76 (1.25-2.50) 0.001 4.32 (1.67-11.19) 0.003
rs4806660 (T>C) 1.48 (1.042-2.12) 0.028 3.76(1.42-9.91) 0.007
rs10183486 (C>T) 1.53 (1.08-2.18) 0.020 3.29 (1.34-8.09) 0.010
rs2303369 (C>T) 1.39 (0.99-1.95) 0.060 2.40 (1.13-5.10) 0.020
Heterozygote contrast (Aa vs. AA)  Recessive model ( aa vs. Aa+AA)  
rs16991615 (G>A) 1.07 (0.63-1.81) 0.781 3.39 (1.78-6.46) 0.001
rs244715 (A>G) 1.48 (0.90-2.43) 0.119 3.37 (1.22-9.24) 0.018
rs451417 (A>C) 0.85 (0.50-1.45) 0.573 3.20 (1.73-5.92) 0.001
rs1046089 (G>A) 1.45 (0.87-2.41) 0.152 2.86 (1.37-5.96) 0.005
rs7246479 (G/T) 1.92 (1.16-3.18) 0.010 2.97 (1.20-7.32) 0.018
rs4806660 (T>C) 1.21 (0.74-1.97) 0.433 3.41 (1.33- 8.74) 0.010
rs10183486 (C>T) 1.34 (0.82-2.19) 0.240 2.84 (1.20- 6.73) 0.020
rs2303369 (C>T) 1.1(0.66-1.82) 0.710 2.28 (1.13-4.58) 0.020
SNP; Single nucleotide polymorphism, OR; Odds ratio, and CI; Confidence interval.
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Table 4: Association between the SNPs and demographic characteristics



















AA (n=134) Mean 1.54604 95.5396 69.8507 105.3455 61.8738 0.9069 30.7632 29.2723
SD 0.059774 11.59249 11.74 9.636 7.79393 0.07493 4.06007 4.89012
Aa+aa (n=166) Mean 1.54366 94.4811 69.1659 105.1543 61.2964 0.8992 30.9902 29.0056
SD 0.058927 10.96122 11.19606 8.85304 7.52282 0.07828 4.93033 4.29641
P value* 0.730 0.420 0.608 0.859 0.517 0.386 0.670 0.617
rs244715  
AA (n=172) Mean 1.54413 94.932 68.443 104.625 61.5679 0.9077 30.4241 28.722
SD 0.058418 11.08496 10.86428 8.78544 7.605 0.07768 2.99326 4.37843
Aa+aa (n=128) Mean 1.54556 94.9913 70.881 106.0802 61.5399 0.8958 31.5143 29.6764
SD 0.060525 11.49888 12.06058 9.70565 7.71405 0.07526 6.01161 4.77505
P value 0.838 0.964 0.069 0.178 0.975 0.186 0.042 0.075
rs451417  
AA (n=135) Mean 1.5443 95.0711 68.9215 105.0119 61.6286 0.9056 30.6828 28.8994
SD 0.061006 11.20656 10.88902 8.65259 7.47528 0.07947 3.80482 4.27702
Aa+aa (n=165) Mean 1.54509 94.8626 69.9313 105.4294 61.496 0.9002 31.058 29.3128
SD 0.057888 11.30614 11.87232 9.64887 7.7933 0.0746 5.09652 4.79884
P value 0.908 0.874 0.449 0.697 0.882 0.549 0.481 0.438
rs1046089  
AA (n=108) Mean 1.53991 94.9944 69.0157 105.1648 61.7733 0.9031 30.5252 29.1215
SD 0.055895 10.98759 11.2755 8.80033 7.57492 0.0696 3.06539 4.63562
Aa+aa (n=192) Mean 1.54747 94.9358 69.7342 105.2832 61.4326 0.9024 31.0937 29.1279
SD 0.061005 11.41384 11.53757 9.43923 7.69138 0.08073 5.20816 4.53979
P value 0.290 0.966 0.603 0.915 0.712 0.938 0.303 0.991
rs7246479  
AA (n=125) Mean 1.53992 95.5864 70.3928 105.2984 62.132 0.9078 30.722 29.6871
SD 0.060728 10.95757 11.09858 9.25444 7.25764 0.06692 3.85928 4.40168
Aa+aa (n=175) Mean 1.54821 94.5023 68.8098 105.1983 61.1399 0.899 31.0064 28.7198
SD 0.058037 11.45425 11.64944 9.18376 7.89665 0.08315 4.99693 4.65319
P value 0.234 0.412 0.239 0.926 0.269 0.329 0.597 0.071
rs4806660  
AA (n=144) Mean 1.54222 96.3625 67.6604 104.7625 62.5597 0.92 30.5895 28.4628
SD 0.056426 11.34757 11.4973 8.87954 7.68153 0.07821 3.12603 4.67753
Aa+aa (n=156) Mean 1.54708 93.6429 71.1695 105.687 60.6176 0.8864 31.1673 29.7452
SD 0.061813 11.0187 11.13753 9.4933 7.50157 0.07191 5.5638 4.38612
P value 0.480 0.037 0.008 0.387 0.028 <0.001 0.276 0.015
rs10183486  
AA (n=140) Mean 1.55436 96.3093 71.2586 106.7629 62.054 0.9025 31.3266 29.491
SD 0.061752 10.84882 11.72958 9.3348 7.45174 0.07029 4.26855 4.52896
Aa+aa (n=160) Mean 1.5362 93.7589 67.8924 103.8911 61.1148 0.9028 30.5 28.8017
SD 0.055702 11.48176 10.95238 8.8882 7.79695 0.0823 4.77225 4.59034
P value 0.008 0.050 0.011 0.007 0.290 0.975 0.119 0.194
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Table 5: Univariate multivariate analysis of the polymorphisms between 















Waist circumference (cm) 0.439
Weight (kg) 0.830
Hip circumference (cm) 0.938
Waist: height ratio 0.550
Waist:hip ratio 0.348
Mid upper circumference (cm) 0.332
Body mass index (kg/m2) 0.463
Univariate and multivariate linear regression were used to indicate the polymorphisms 
correlations. *; Due to multiple comparison, Bonferroni correction was applied and the 
level of significance was set to <0.003.
Association of the single nucleotide polymorphisms 
with demographic characteristics
We found no significant association between 
rs16991615, rs451417 and rs1046089 polymorphisms and 
demographic characteristics of the patients. Additionally, 
only the rs244715 showed an association with Mid-Upper 
Arm Circumference (MUAC) in which the dominant 
homozygous genotype had lower MUAC (P=0.042). WC 
and weight did not seem to be associated with rs4806660, 
rs10183486 and rs2303369 (P=0.05). In all of these 
three SNPs, the dominant homozygous genotype had a 
greater WC. On the other hand, people with the dominant 
homozygous genotype of rs10183486 were heavier, 
while the same genotype for rs2303369 and rs4806660 
had lower weight. Hip circumference only showed 
association with rs10183486, as dominant homozygous 
genotype. Furthermore, waist/height and waist/hip ratios 
were significantly higher for the dominant homozygous 
genotype of rs4806660 and rs2303369. Finally, women 
having TT and CC genotypes for the rs4806660 and 
rs2303369, respectively, had significantly higher 
BMI. The association of these SNPs and demographic 
characteristics are summarized in Table 4. However, 
after correcting for multiple testing using Bonferroni 
correction, they were not remained significant. Moreover, 
univariate regression analysis (model 1) was used to 
analyze the association between genetic variants and risk 
of POI. While, multivariate regression analysis (model 
2) was adjusted for sex, age, smoking status, BMI, WC, 
waist/hip, waist/height.
Discussion
We evaluated association of eight different SNPs 
including rs16991615, rs244715, rs451417, rs1046089, 
rs7246479, rs4806660, rs10183486 and rs2303369 with 
premature menopause. All of these SNPs except for 
rs244715, rs7246479 and rs4806660 were previously 
identified in GWAS. These SNPs are mapped to different 
loci in the genome. rs16991615 and rs451417 are mapped 
to MCM8 while rs2303369, rs1046089, rs10183486 and 
rs244715 are mapped to FNDC4, PRRC2A, TLK1 and 
ZNF346, respectively. Besides, rs7246479 and rs4806660 
are both mapped to TMEM150B. 
Several studies have established the role of genetic 
variations in premature menopause. One of the loci is 
located on chromosome 19 containing MCM8, which 
encodes a mini-chromosome maintenance protein called 
DNA replication licensing factor MCM8. MCM8 plays 
role in DNA repair (16). Moreover, this protein has an 
important role in gametogenesis as MCM8 knocked-
out mice showed sterility and arrested primary follicles 
in males and females, respectively (20). Additionally, 
MCM8 expression was increased during the follicular 
phase of menstrual cycle in humans (21). Mutations in 
this gene have been linked to ovarian failure as well 
as chromosomal instability (15, 22). Recently, novel 
mutations of this gene were also identified to associate 
with POI (23, 24). Large scale studies were previously 
conducted and they found that rs16991615 was associated 
with ANM in American populations with Hispanic, 
African and Indian descent, in addition to European 
Table 4: Contineud



















AA (n=119) Mean 1.54345 96.8336 67.5714 104.9563 62.8264 0.9232 30.7568 28.3835
SD 0.054779 11.18619 11.66716 8.84538 7.69302 0.08058 2.98854 4.79756
Aa+aa 
(n=181)
Mean 1.54559 93.7095 70.7385 105.4291 60.7116 0.889 30.9753 29.6188
SD 0.062135 11.1368 11.12204 9.44499 7.50472 0.07112 5.35162 4.35084
 P value 0.760 0.019 0.019 0.665 0.019 <0.001 0.687 0.022
*; Due to multiplecomparison, Bonferroni correction has been applied and the level of significance is set to <0.006 and SNP; Single-nucleotide polymorphism.
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women (17). This SNP was discovered to ramp up the 
risk of premature menopause (25). Bae et al. (26) and 
Day et al. (27) studies revealed association of rs16991615 
with age at menopause at a genome-wide significance. 
The rs16991615 association with age at menopause 
was also replicated in the Iranian population (28). We 
identified that a minor allele of rs16991615 and TT 
genotype is not associated with increased risk of POI 
in our population. Similar to our results, Setti et al. (29) 
found no significant association between rs16991615 and 
poor ovarian response in Brazilian women. Moreover, 
other studies including Desai et al. (16) could not find 
any association between rs16991615 and POI. Recently, 
the minor allele of rs16991615 has been demonstrated 
to increase age-adjusted inverse anti-mullerian hormone 
(AMH), suggesting that factors affecting age at premature 
menopause could have a role in AMH regulation in ovarian 
reserves (30). For other SNPs including rs451417, we 
found that CC genotype was associated with an increased 
risk of POI by more than two-fold in comparison with 
careers of T allele.
We also investigated association of premature menopause 
with the rs244715, located in the ZNF346 gene. ZNF346 
encodes a double-stranded RNA binding protein and takes 
part in apoptosis regulation (31). We confirmed that the 
minor allele of rs244715 could have an association with 
increased risk of the disease and MUAC; however, the 
study on Brazilian women failed to find any association 
between rs244715 and poor ovarian response (29).
Furthermore, Perry et al. (32) and Stolk et al. (14) 
found an association between rs1046089, located in 
the PRRC2A gene that encodes the HLA-B associated 
transcript, with age at menopause. Variations in this gene 
have been linked to different phenotypes, including BMI 
and height. Consistent with this, we noticed that the TT 
genotype of rs1046089 compared to C allele careers could 
be linked with increased risk of POI by more than 150%. 
However, Llácer et al. (19) found an increased risk of poor 
ovarian response in patients with CT and CC genotype, in 
comparison with TT genotype.
The rs7246479 and rs4806660 are located on 
chromosome 19 in the TMEM150B gene, which gives 
rise to transmembrane protein 150B, a member of 
TMEM150/Damage-Regulated Autophagy Modulator 
(DRAM) family. DRAM proteins play a role in apoptosis 
and autophagy (33). We found that women carrying GG 
genotype of rs7246479 were younger and had a lower rate 
of POI. Moreover, this SNP is also associated with age at 
menopause in the Chinese population (13). Furthermore, 
Setti et al. (29) found that rs4806660 has a protective effect 
against poor ovarian response. They further identified 
that the minor allele of rs4806660 was associated with 
enhanced controlled ovarian stimulation. However, the 
association was not statistically significant. Nonetheless, 
we demonstrated that C allele in the recessive model 
could associate with an increased risk of POI.
Another SNP associated with early menopause is 
rs2303369. The gene containing this variant encodes a 
protein called FNDC4. FNDC4 belong to the fibronectin 
type III domain family of proteins. FNDC4 binds to 
macrophages and monocytes. Administration of this could 
have therapeutic applications in inflammatory diseases 
(34). FNDC4 can also activate Wnt/β-catenin signaling 
pathway (35). Although Laisk-Podar et al. (36) established 
the association of rs2303369 with early follicular FSH, 
they could not find any association between rs2303369 
and mean ovarian volume. On the other hand, we found 
that TT genotype of rs2303369 was associated with a 
significantly increased risk of POI in comparison with the 
major allele careers.
rs10183486 in the Tousled-like kinase 1 (TLK1) gene, 
encoding a serine/threonine kinase, is suggested to be 
involved in chromatin assembly, DNA repair and ovarian 
aging (37). Overexpression of TLK1 in mouse embryonic 
stem cells has resulted in developmental arrest and 
apoptosis, as well as a decrease in pluripotency factors (38). 
We found that the minor allele of rs10183486 in comparison 
with the C allele and TT genotype in comparison with C 
allele careers (CT+CC) were associated with increased 
susceptibility to POI which is in concordance with the 
findings of Stolk et al. (14) study, reported an association 
between rs10183486 SNP and age at menopause.
Limitations of the current study include use of a population 
derived from a single region of Iran, hence it may not be 
possible to extrapolate our findings more widely. Secondly, 
we were unable to completely verify premature menopause 
by biochemical testing. Thirdly, the sample size of this 
study was quite small, which may affect the power of this 
study. Hence, there is a need to conduct further studies in 
different ethnicities with large sample sizes and to consider 
more comprehensive criteria for assessing the correlation 
between variants and premature menopause. 
Conclusion 
The rs16991615, rs244715, rs451417, rs1046089, 
rs7246479, rs4806660, rs10183486 and rs2303369 
polymorphisms may potentially influence premature 
menopause. Although ethnic differences may result in 
diverse outcomes in association studies, more commonly 
recognized loci related to age at menopause could be 
subjected to replication in different populations. This 
could warrant further investigations with larger sample 
sizes to get a more comprehensive understanding of 
variations in different geographic regions. 
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